These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7525808)

  • 1. [Hematopoietic factors: cytokine].
    Hirashima K
    Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):368-72. PubMed ID: 7525808
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of G-CSF in hematological disorders].
    Dan K
    Rinsho Ketsueki; 1997 May; 38(5):367-70. PubMed ID: 9194376
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basic facts and clinical application of hematopoietic factors].
    Hirashima K
    Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):482-6. PubMed ID: 7525810
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation without protective environment: evaluation of infectious complications.
    Gallardo D; Alonso E; Español I; de la Banda E; Ferrá C; Berlanga JJ; Grañena A
    Transplant Proc; 1995 Aug; 27(4):2353. PubMed ID: 7544502
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
    [No Abstract]   [Full Text] [Related]  

  • 6. The levels of granulocyte colony-stimulating factor in the plasma of the bone marrow aspirate in various hematological disorders.
    Shinohara K; Oeda E; Nomiyama J; Inoue H; Kamei S; Tajiri M; Ichikawa T; Kuwaki T; Tachibana K
    Stem Cells; 1995 Jul; 13(4):421-7. PubMed ID: 7549901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of colony stimulating factors in the treatment of aplastic anemia].
    Domingo Morera JM; Palomera Bernal L; Agulló Alcober JA; Olave Rubio MT
    Med Clin (Barc); 1994 Dec; 103(20):799. PubMed ID: 7532252
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation.
    Buckner CD; Sanders JE; Storb R
    Prog Clin Biol Res; 1989; 309():317-23. PubMed ID: 2675100
    [No Abstract]   [Full Text] [Related]  

  • 9. [Late effects of treatment with recombinant human granulocyte colony-stimulating factor in patients with aplastic anemia].
    Kojima S
    Rinsho Ketsueki; 1997 May; 38(5):371-4. PubMed ID: 9194377
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
    Motoyoshi K
    Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Utilization of colony-stimulating factors in severe aplastic anemia].
    Javier G; Sábado C; Prats J
    Sangre (Barc); 1994 Apr; 39(2):146-7. PubMed ID: 7520195
    [No Abstract]   [Full Text] [Related]  

  • 12. [GM-CSF.G-CSF].
    Kitamura K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):301-5. PubMed ID: 7531964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow transplantation in blood diseases and neoplasms].
    Robak T
    Postepy Hig Med Dosw; 1985; 39(5):465-517. PubMed ID: 3915351
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of colony-stimulating factors in primary hematologic disorders.
    Nimer SD
    Cancer; 1992 Aug; 70(4 Suppl):921-7. PubMed ID: 1638464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with growth factors and cytokines in hematologic diseases].
    Waage A; Dahl IM; Evensen SA; Holte H; Lamvik J; Sletnes K; Wisløff F
    Tidsskr Nor Laegeforen; 1996 May; 116(12):1465-9. PubMed ID: 8650635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hematopoietic factors: serum concentrations and clinical application].
    Urabe A; Iki S; Usukine K
    Rinsho Ketsueki; 1997 May; 38(5):360-3. PubMed ID: 9194374
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stimulation of myelopoiesis by G-CSF (Filgastrim) in a case oc severe aplastic anemia].
    Domingo JM; Palomera L; Ansó V; Agulló JA; Olave MT
    Sangre (Barc); 1993 Dec; 38(6):501-2. PubMed ID: 7513445
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methods of autologous peripheral blood stem cell (PBSC) mobilization in oncological and hematological patients].
    Fregatova LM; Shavva SA; Platonova GG; Golovacheva AA; Afanas'ev BV
    Vopr Onkol; 1999; 45(4):380-3. PubMed ID: 10532095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion.
    Fields KK; Elfenbein GJ; Perkins JB; Janssen WE; Ballester OF; Hiemenz JW; Zorsky PE; Kronish LE; Foody MC
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):86-92. PubMed ID: 7527592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications of G-CSF administration in hematologic disorders].
    Lionne-Huyghe P; Kuhnowski F; Coiteux V; Bauters F; Morschhauser F
    Bull Cancer; 2006 May; 93(5):453-62. PubMed ID: 16777623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.